Recommendation 1
Addressed to: The Health Board
No Response Published
Link to recommendation Recommendation 1
Recommendation · source text
The Health Board should publish a formal response to the learning which has emerged from the first phase of the Clinical Review Programme (the maternal category) to coincide with the publication of the Panel’s thematic report. In particular, the response should explain what the Health Board has already done to address the learning through the delivery of its Maternity Improvement Plan and set out what it intends to do going forward, particularly in response to any new learning which has emerged from the Clinical Review Programme. The response should also explain how it is supporting the women and families involved in the reviews and how it intends to use the opportunity presented by the Clinical Review Programme to rebuild public trust and confidence going forward.
Recommendation 2
Addressed to: The Health Board
No Response Published
Link to recommendation Recommendation 2
Recommendation · source text
The Health Board should be asked to work with the Welsh Government and the Maternity and Neonatal Network to ensure that the opportunities for wider learning which have emerged from the Clinical Review Programme are identified and shared on an all-Wales basis. Notwithstanding that the Health Board has yet to publish its more detailed evaluation, it is already clear that there is significant learning to be derived from the first phase of the Clinical Review Programme which might not only benefit the Health Board but be of wider benefit to other Health Boards in Wales. The Panel believes that there are two particular aspects which might provide useful learning for others. The first relates to the clinical and operational learning which has emerged from the reviews themselves. The second relates to the systems and processes which the Health Board has put in place, working collaboratively with the Panel, the Welsh Government and the NHS Wales Delivery Unit to manage the implications of the Clinical Review Programme and in particular the interface with the women and families involved. The experience which the Health Board has gained in developing these arrangements would provide a rich source of learning for others seeking to enhance their internal clinical review processes with a genuine focus on putting the needs and expectation of women and families at the heart of the process.